K Irsigler

2.4k total citations
125 papers, 1.5k citations indexed

About

K Irsigler is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, K Irsigler has authored 125 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Physiology and 17 papers in Surgery. Recurrent topics in K Irsigler's work include Diabetes Management and Research (31 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (17 papers) and Diabetes and associated disorders (15 papers). K Irsigler is often cited by papers focused on Diabetes Management and Research (31 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (17 papers) and Diabetes and associated disorders (15 papers). K Irsigler collaborates with scholars based in Austria, Germany and United Kingdom. K Irsigler's co-authors include Thomas Kästenbauer, Martin Auinger, Gerald H. Sokol, S Sauseng, H Kritz, Harald Kritz, Heidemarie Abrahamian, Hartmut Zwick, D. Formanek and Rudolf Prager and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

K Irsigler

114 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Irsigler Austria 22 694 279 267 204 159 125 1.5k
Roberto Anichini Italy 27 936 1.3× 412 1.5× 280 1.0× 182 0.9× 66 0.4× 74 2.0k
Martin Pfohl Germany 19 872 1.3× 359 1.3× 259 1.0× 312 1.5× 345 2.2× 69 2.0k
J. E. Tooke United Kingdom 26 842 1.2× 562 2.0× 799 3.0× 619 3.0× 75 0.5× 66 2.2k
Jay D. Coffman United States 22 382 0.6× 712 2.6× 430 1.6× 478 2.3× 66 0.4× 59 2.1k
T Sane Finland 21 569 0.8× 321 1.2× 336 1.3× 160 0.8× 84 0.5× 34 1.2k
Renzo Navalesi Italy 28 1.1k 1.6× 791 2.8× 320 1.2× 405 2.0× 304 1.9× 135 2.6k
M. Nattrass United Kingdom 26 1.1k 1.6× 536 1.9× 452 1.7× 242 1.2× 427 2.7× 125 2.1k
Mohammad Pajouhi Iran 19 621 0.9× 168 0.6× 311 1.2× 51 0.3× 120 0.8× 42 1.5k
Zilin Sun China 23 723 1.0× 277 1.0× 477 1.8× 371 1.8× 141 0.9× 88 1.9k
Çağatay Öktenli Türkiye 25 422 0.6× 261 0.9× 386 1.4× 246 1.2× 94 0.6× 78 2.1k

Countries citing papers authored by K Irsigler

Since Specialization
Citations

This map shows the geographic impact of K Irsigler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Irsigler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Irsigler more than expected).

Fields of papers citing papers by K Irsigler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Irsigler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Irsigler. The network helps show where K Irsigler may publish in the future.

Co-authorship network of co-authors of K Irsigler

This figure shows the co-authorship network connecting the top 25 collaborators of K Irsigler. A scholar is included among the top collaborators of K Irsigler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Irsigler. K Irsigler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willinger, Christine, et al.. (2008). Morbidität und Letalität bei Typ-I- und Typ-II-Diabetikern nach Diagnose einer diabetischen Retinopathie. DMW - Deutsche Medizinische Wochenschrift. 117(45). 1703–1708.
2.
Abrahamian, Heidemarie, et al.. (2008). Rezidivierende Hypoglykämien und Lactatacidose bei Non-Hodgkin-Lymphom. DMW - Deutsche Medizinische Wochenschrift. 116(38). 1428–1432. 3 indexed citations
3.
Abrahamian, Heidemarie, Georg Endler, Markus Exner, et al.. (2007). Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory Cytokines. Experimental and Clinical Endocrinology & Diabetes. 115(1). 38–41. 35 indexed citations
4.
Kästenbauer, Thomas, et al.. (2004). Progression and distribution of plantar pressure in Type 2 diabetic patients.. PubMed. 17(2). 108–13. 18 indexed citations
5.
Kästenbauer, Thomas & K Irsigler. (2003). The Diabetic Foot Syndrome. Wiener Medizinische Wochenschrift. 153(21-22). 474–477. 7 indexed citations
6.
Kästenbauer, Thomas, et al.. (2003). Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia. 46(1). 27–30. 44 indexed citations
7.
Kästenbauer, Thomas, S Sauseng, Gerald H. Sokol, Martin Auinger, & K Irsigler. (2001). A Prospective Study of Predictors for Foot Ulceration in Type 2 Diabetes. Journal of the American Podiatric Medical Association. 91(7). 343–350. 62 indexed citations
8.
Buyken, Anette E., M. Toeller, G. Heitkamp, et al.. (2000). Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. Diabetic Medicine. 17(5). 351–359. 35 indexed citations
9.
Irsigler, K, et al.. (1997). [Retrospective analysis of the incidence of severe hypoglycemia in 458 type 1 diabetic patients].. PubMed. 24(5). 165–9. 2 indexed citations
10.
Auinger, Martin, et al.. (1997). Normocalcaemic hepatorenal sarcoidosis with crescentic glomerulonephritis. Nephrology Dialysis Transplantation. 12(7). 1474–1477. 9 indexed citations
11.
Abrahamian, Heidemarie, et al.. (1994). [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].. PubMed. 106(5). 136–40. 3 indexed citations
12.
Kästenbauer, Thomas, Martin Auinger, & K Irsigler. (1994). [Prevalence of cardiac autonomic neuropathies in uremia and diabetes mellitus].. PubMed. 106(23). 733–7. 4 indexed citations
13.
Wanke, T., Wolfgang Grisold, D. Formanek, et al.. (1992). Phrenic Nerve Function in Type 1 Diabetic Patients with Diaphragm Weakness and Peripheral Neuropathy. Respiration. 59(4). 233–237. 28 indexed citations
14.
Wanke, T., D. Formanek, Martin Auinger, et al.. (1992). Mechanical load on the inspiratory muscles during exercise hyperpnea in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 35(5). 425–428. 2 indexed citations
15.
Formanek, D., et al.. (1992). Pulmonary Gas Exchange and Oxygen Uptake During Exercise in Patients with Type 1 Diabetes Mellitus. Diabetic Medicine. 9(3). 252–257. 31 indexed citations
16.
Wanke, T., D. Formanek, Martin Auinger, et al.. (1991). Inspiratory Muscle Performance and Pulmonary Function Changes in Insulin-dependent Diabetes Mellitus. American Review of Respiratory Disease. 143(1). 97–100. 69 indexed citations
17.
Irsigler, K, et al.. (1984). Effect of a single oral dose of acipimox on glucose utilization after intravenous glucose load in obese patients. 10. 621–625. 8 indexed citations
18.
Irsigler, K, et al.. (1981). New Approaches to insulin therapy : proceedings of the 2nd Vienna-Lainz Diabetes Symposium, Vienna, Austria, April 23-26, 1980.
19.
Irsigler, K, et al.. (1977). [Investigations of the effect of midodrine on carbohydrate and fat metabolism with particular reference to the diabetic metabolic state (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 89(5). 164–7. 2 indexed citations
20.
Irsigler, K, et al.. (1971). Effects of metabolism of hexoprenalin. Wiener klinische Wochenschrift. 83(5). 75–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026